News
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our commitment to quality and reliability...
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our commitment to quality and reliability...
Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control...
BioConnection to manufacture clinical trial material for Nykode Therapeutics’ vaccine
Oss, The Netherlands, 29 November 2021 BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The...
GMP certification for new large scale filling line
Oss, The Netherlands, June 28, 2021. BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and...
BioConnection is honoured to support VarmX
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory...
AdaptVac partners with BioConnection to manufacture their COVID-19 vaccine
BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine in its...
BioConnection is honoured that AIMM Therapeutics has become our customer.
With our capabilities from our facility in Oss, the Netherlands, we are able to assist AIMM Therapeutics in the development of their groundbreaking...